The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Turtle Cameron since 2019.
This trader's CIK number is 1758363.
At the time of last reporting, Turtle Cameron was the Chief Executive Officer of Spyre Therapeutics, Inc.. (stock ticker symbol SYRE).
Also see all insider trading activities at Spyre Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | SYRE | 0 | $0 | 45,000 | $1,052,775 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | EIDX | 0 | $0 | 89,704 | $6,552,093 | 56,294 | $840,539 |
| 2019 | EIDX | 0 | $0 | 35,000 | $1,668,330 | 10,000 | $132,000 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | BBIO | 0 | $0 | 83,307 | $3,640,882 | 80,500 | $788,001 |
| 2019 | BBIO | 0 | $0 | 0 | $0 | 12,630 | $0 |
1. Spyre Therapeutics, Inc. (SYRE)
2. Eidos Therapeutics, Inc. (EIDX)
3. Bridgebio Pharma, Inc. (BBIO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-11-03 | SYRE | Sale | 45,000 | 23.39 | 1,052,775 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-15 | EIDX | Option Ex | 26,294 | 15.10 | 397,039 |
| 2020-12-15 | EIDX | Sale | 26,294 | 111.69 | 2,936,750 |
| 2020-11-11 | EIDX | Sale | 13,410 | 74.51 | 999,219 |
| 2020-11-02 | EIDX | Sale | 12,500 | 71.32 | 891,487 |
| 2020-11-02 | EIDX | Option Ex | 7,500 | 15.10 | 113,250 |
| 2020-09-10 | EIDX | Option Ex | 2,500 | 17.00 | 42,500 |
| 2020-09-10 | EIDX | Sale | 2,500 | 47.00 | 117,500 |
| 2020-08-03 | EIDX | Sale | 10,000 | 40.06 | 400,630 |
| 2020-08-03 | EIDX | Option Ex | 5,000 | 13.20 | 66,000 |
| 2020-05-26 | EIDX | Sale | 2,500 | 47.00 | 117,500 |
| 2020-05-26 | EIDX | Option Ex | 2,500 | 17.00 | 42,500 |
| 2020-05-01 | EIDX | Option Ex | 5,000 | 13.20 | 66,000 |
| 2020-05-01 | EIDX | Sale | 10,000 | 41.89 | 418,920 |
| 2020-02-03 | EIDX | Option Ex | 7,500 | 15.10 | 113,250 |
| 2020-02-03 | EIDX | Sale | 12,500 | 53.61 | 670,087 |
| 2019-12-06 | EIDX | Option Ex | 10,000 | 13.20 | 132,000 |
| 2019-12-06 | EIDX | Sale | 10,000 | 58.18 | 581,820 |
| 2019-11-20 | EIDX | Sale | 10,000 | 55.95 | 559,510 |
| 2019-09-04 | EIDX | Sale | 5,000 | 41.80 | 209,000 |
| 2019-06-04 | EIDX | Sale | 10,000 | 31.80 | 318,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-28 | BBIO | Option Ex | 19,500 | 5.83 | 113,743 |
| 2020-12-28 | BBIO | Sale | 19,500 | 69.64 | 1,357,902 |
| 2020-11-25 | BBIO | Sale | 742 | 47.23 | 35,043 |
| 2020-11-24 | BBIO | Sale | 4,258 | 47.00 | 200,138 |
| 2020-11-25 | BBIO | Option Ex | 742 | 17.00 | 12,614 |
| 2020-11-24 | BBIO | Option Ex | 4,258 | 17.00 | 72,386 |
| 2020-11-05 | BBIO | Option Ex | 2,500 | 17.00 | 42,500 |
| 2020-11-05 | BBIO | Sale | 2,500 | 42.05 | 105,125 |
| 2020-09-30 | BBIO | Option Ex | 14,500 | 5.83 | 84,578 |
| 2020-09-30 | BBIO | Sale | 14,500 | 37.92 | 549,825 |
| 2020-09-18 | BBIO | Sale | 2,500 | 42.01 | 105,025 |
| 2020-09-18 | BBIO | Option Ex | 2,500 | 17.00 | 42,500 |
| 2020-09-15 | BBIO | Option Ex | 2,500 | 17.00 | 42,500 |
| 2020-09-15 | BBIO | Sale | 2,500 | 37.06 | 92,652 |
| 2020-09-11 | BBIO | Option Ex | 2,000 | .34 | 680 |
| 2020-09-11 | BBIO | Sale | 2,000 | 35.02 | 70,048 |
| 2020-06-30 | BBIO | Option Ex | 10,000 | .25 | 2,500 |
| 2020-06-30 | BBIO | Sale | 10,000 | 32.91 | 329,099 |
| 2020-04-27 | BBIO | Option Ex | 2,000 | 17.00 | 34,000 |
| 2020-04-27 | BBIO | Sale | 2,000 | 32.01 | 64,028 |
| 2020-04-08 | BBIO | Sale | 8,000 | 27.05 | 216,360 |
| 2020-04-08 | BBIO | Option Ex | 8,000 | 17.00 | 136,000 |
| 2020-02-11 | BBIO | Sale | 2,000 | 37.28 | 74,564 |
| 2020-02-11 | BBIO | Option Ex | 2,000 | 17.00 | 34,000 |
| 2020-01-08 | BBIO | Sale | 12,807 | 34.44 | 441,073 |
| 2020-01-08 | BBIO | Option Ex | 10,000 | 17.00 | 170,000 |
| 2019-07-01 | BBIO | Option Ex | 12,630 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Turtle Cameron (Chief Executive Officer of Spyre Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.